Design and synthesis of novel pyrimidine hydroxamic acid inhibitors of histone deacetylases

被引：5

作者：

Donald, Alastair D. G. ^{[1
]}

Clark, Vanessa L. ^{[1
]}

Patel, Sanjay ^{[1
]}

Day, Francesca A. ^{[1
]}

Rowlands, Martin G. ^{[2
]}

Wibata, Judata ^{[2
]}

Stimson, Lindsay ^{[2
]}

Hardcastle, Anthea ^{[2
]}

Eccles, Sue A. ^{[2
]}

McNamara, Deborah ^{[1
]}

Needham, Lindsey A. ^{[1
]}

Raynaud, Florence I. ^{[2
]}

Aherne, Wynne ^{[2
]}

Moffat, David F. ^{[1
]}

机构：

[1] Chroma Therapeut, Abingdon OX14 4RY, Oxon, England

[2] Inst Canc Res, Canc Res UK Canc Therapeut Unit, Surrey SM2 5NG, England

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 22期

关键词：

HDAC; Cancer; Optimisation; PROMISE;

D O I：

10.1016/j.bmcl.2010.09.016

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Inhibition of histone deacetylase activity represents a promising new modality in the treatment of a number of cancers. A novel HDAC series demonstrating inhibitory activity in cell proliferation assays is described. Optimisation based on the introduction of basic amine linkers to effect good drug distribution to tumour led to the identification of a compound with oral activity in a human colon cancer xenograft study associated with increased histone H3 acetylation in tumour tissue. (C) 2010 Elsevier Ltd. All rights reserved.

引用

页码：6657 / 6660

页数：4

共 50 条

[41] Synthesis and biological evaluation of a new series of histone deacetylases inhibitors
Jiao, Jie
Wang, Qiang
Zhu, Hua Wei
Fang, Hao
Xu, Wen Fang
CHINESE CHEMICAL LETTERS, 2008, 19 (06) : 673 - 675
[42] Benzimidazole and imidazole inhibitors of histone deacetylases: Synthesis and biological activity
Bressi, Jerome C.
de Jong, Ron
Wu, Yiqin
Jennings, Andy J.
Brown, Jason W.
O'Connell, Shawn
Tari, Leslie W.
Skene, Robert J.
Vu, Phong
Navre, Marc
Cao, Xiaodong
Gangloff, Anthony R.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (10) : 3138 - 3141
[43] Design, Synthesis, and Antiproliferative Activity of Selective Histone Deacetylases 6 Inhibitors Containing a Tetrahydropyridopyrimidine Scaffold
Wang, Bin
Liu, Youcai
Zhang, Lejing
Wang, Yajuan
Li, Zhaoxi
Chen, Xin
MOLECULES, 2023, 28 (21):
[44] Novel hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
Curtin, ML
Garland, RB
Frey, RR
Heyman, HR
Michaelides, MR
Li, JL
Pease, LJ
Glaser, KB
Marcotte, PA
Davidsen, SK
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U28 - U28
[45] Chlamydocin-hydroxamic acid analogues as histone deacetylase inhibitors
Nishino, N
Jose, B
Shinta, R
Kato, T
Komatsu, Y
Yoshida, M
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (22) : 5777 - 5784
[46] Design, synthesis and preliminary activity assay of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as novel Histone deacetylases (HDACs) inhibitors
Zhang, Yingjie
Feng, Jinhong
Liu, Chunxi
Zhang, Lei
Jiao, Jie
Fang, Hao
Su, Li
Zhang, Xiaopan
Zhang, Jian
Li, Minyong
Wang, Binghe
Xu, Wenfang
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (05) : 1761 - 1772
[47] Design and synthesis of aryl ether and sulfone hydroxamic acids as potent histone deacetylase (HDAC) inhibitors
Pabba, Chittari
Gregg, Brian T.
Kitchen, Douglas B.
Chen, Zhen Jia
Judkins, Angela
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (01) : 324 - 328
[48] Design, synthesis and biological evaluation of novel hydroxamic acid-derived histone deacetylase inhibitors bearing a 2-oxoindoline scaffold as potential antitumor agents
Huong, Tran Thi Lan
Kim, Hwa Kyung
Thien, Nguyen Duc
Dung, Do Thi Mai
Kim, Ji Su
Kim, Jiyeon
Kang, Jong Soon
Oanh, Dao Thi Kim
Tung, Truong Thanh
Thang, Nguyen Quoc
Anh, Duong Tien
Han, Sang-Bae
Nam, Nguyen-Hai
BIOORGANIC & MEDICINAL CHEMISTRY, 2025, 122
[49] Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
Hassell, Kelly N.
DISEASES, 2019, 7 (04)
[50] The application of histone deacetylases inhibitors in glioblastoma
Chen, Rui
Zhang, Mengxian
Zhou, Yangmei
Guo, Wenjing
Yi, Ming
Zhang, Ziyan
Ding, Yanpeng
Wang, Yali
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2020, 39 (01)

← 1 2 3 4 5 →